Vanguard Russell 2000 Index’s competitive fee, broad reach, and market-cap-weighted portfolio are compelling features. But flaws in the Russell 2000 Index’s process raise trading costs and place greater emphasis on volatile, low-quality companies.
Vanguard Russell 2000 Index Fund Institutional Shares VRTIX
- NAV / 1-Day Return 434.98 / +0.94 %
- Total Assets 17.9B
-
Adj. Expense Ratio
0.050%
- Expense Ratio 0.070%
- Distribution Fee Level Low
- Share Class Type Institutional
- Category Small Blend
- Investment Style Small Blend
- Min. Initial Investment 5M
- Status Open
- TTM Yield 1.22%
- Turnover 14%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:10 AM GMT+0
Morningstar’s Analysis VRTIX
Will VRTIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 3.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Slbbh1142 | 1.97 | 361M | Cash and Equivalents |
JFrog Ltd Ordinary Shares | 0.34 | 63M | Technology |
Moog Inc Class A | 0.33 | 61M | Industrials |
UMB Financial Corp | 0.33 | 60M | Financial Services |
Glaukos Corp | 0.32 | 60M | Healthcare |
Brinker International Inc | 0.31 | 57M | Consumer Cyclical |
BrightSpring Health Services Inc | 0.30 | 55M | Healthcare |
Krystal Biotech Inc | 0.29 | 54M | Healthcare |
Cytokinetics Inc | 0.29 | 54M | Healthcare |
Protagonist Therapeutics Inc | 0.28 | 52M | Healthcare |